USFDA:

 Lupin has received USFDA approval for its Abbreviated New Drug Application (ANDA), Efinaconazole Topical Solution, 10% to market a generic equivalent of Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. 

 Source:https://www.business-standard.com/article/news-cm/lupin-receives-usfda-approval-for-efinaconazole-topical-solution-122030301248_1.html